Cmed Technology to Preview New Innovations to Speed and Streamline Electronic Trials at DIA Conference

By Cmed Technology, PRNE
Tuesday, June 7, 2011

NEW PROVIDENCE, New Jersey, June 8, 2011 -

- Demonstrations to showcase new Timaeus capabilities for faster study
build, earlier go-live dates, more responsive investigator site and
monitoring experience

Cmed Technology (, an innovative provider
of eClinical technology, announced today it will preview its forthcoming
Timaeus Guided Trial Builder product at this month's Drug Information
Association (DIA) Annual Meeting in Chicago, IL. Guided Trial Builder will
introduce an entirely different approach to simplify and streamline the
startup of electronic trials. It expands on the Timaeus on-demand eClinical
platform's history of harnessing innovation to empower clinical research
teams to do more-in more places-with less time and effort.

(Logo: )

Guided Trial Builder will enable non-programmers to rapidly build entire
trials, including visit schedules, pages and edit checks. It automatically
ensures adherence to standards and seamlessly validates the trial during the
build process, eliminating the need for manual quality control (QC) and
hand-off between teams. Adding Guided Trial Builder to Timaeus' on-demand
deployment capabilities allows study teams to start new trials and perform
mid-trial updates at the touch of a button-without downtime or site
interruption. Cmed Technology is currently working with a Top 10
pharmaceutical company to quantify the time and efficiency improvements
Guided Trial Builder will provide.

"Today, more than ever, speed is everything as pharmaceutical and biotech
companies look for faster trial builds, earlier go-live dates and immediate
access to clinical trial data," said Dr. David Connelly, CEO of Cmed. "Guided
Trial Builder expands on our many years of work building eClinical technology
that can rapidly respond to the needs of research organizations. Imagine the
benefits of building and deploying entire study databases in days-rather than
weeks or months."

Cmed Technology will highlight how Timaeus 5
( benefits various clinical trial roles at
its DIA Booth 1662. Visitors will be able to build, immediately deploy and
conduct user acceptance testing (UAT) on trials themselves. They will be able
to capture data, perform source data verification (SDV) and run real-time
reports using Timaeus Web
They also can explore a fast, reliable and secure mobile experience using the
Apple iPad(R) with Timaeus HotSpot
the industry's first portable eClinical suite. To schedule a demonstration,
please send an email to or register online at

About Cmed Technology

Cmed Technology is an innovative provider of eClinical technology and
solutions. Its unified eClinical platform, Timaeus, combines advanced
distributed cloud
and tablet
computing technologies to provide research organizations the freedom to
manage any type of data, for any trial, anywhere. Created in 2002, Timaeus
has been used by biopharmaceutical companies, non-profit institutions, CROs
and other research organizations for early phase, pivotal and late phase
studies. Timaeus provides on-demand solutions for programming of simple,
complex and adaptive trials (Timaeus Trial Builder)
electronic data capture (Timaeus Electronic Data Capture)
monitoring (Timaeus Field Monitoring)
in-stream coding (Timaeus Medical Coding)
electronic, paper, and hybrid trial data management
(Timaeus Electronic Data Management)
and clinical and operational reporting (Timaeus Reporting)
A division of the Cmed Group with roots from the University of Oxford, Cmed
Technology has offices in the United Kingdom, the United States and Romania.
To learn more, visit

    Media Contacts:
    Cmed Technology
    Christopher Leary or +1-908-795-2006

    Randy Wambold or +1-781-672-3119


will not be displayed